|
IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
EP0861660B9
(en)
*
|
1997-02-28 |
2006-06-28 |
Kaneka Corporation |
Curative medicine for disease caused by infection of Helicobacter
|
|
EP1453837A4
(en)
*
|
2001-11-21 |
2007-11-07 |
Activbiotics Inc |
TARGETED THERAPEUTIC AGENTS AND USES THEREOF
|
|
WO2003051299A2
(en)
*
|
2001-12-13 |
2003-06-26 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
US8758804B2
(en)
*
|
2002-11-05 |
2014-06-24 |
Fadim S.R.L. |
Controlled and continued delivery of rifaximin and/or other substances
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
ITMI20032144A1
(it)
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
DK1698630T3
(da)
|
2005-03-03 |
2014-12-08 |
Alfa Wassermann Spa |
Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
KR101327635B1
(ko)
|
2005-08-11 |
2013-11-12 |
타간타 테라퓨틱스 인크. |
포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
|
|
EP1996710B1
(en)
|
2006-03-09 |
2019-08-14 |
Salix Pharmaceuticals, Inc. |
Rifaximin anti-rectal dysfunction preparation
|
|
HUE025306T2
(hu)
|
2006-08-02 |
2016-01-28 |
Salix Pharmaceuticals Inc |
Sugárterápia által okozott bélgyulladás kezelésére irányuló módszer
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
NZ575550A
(en)
*
|
2006-09-22 |
2011-12-22 |
Cipla Ltd |
Rifaximin
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
WO2009008005A1
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
|
EP2011486B2
(en)
|
2007-07-06 |
2015-08-12 |
Lupin Ltd. |
Pharmaceutical compositions of rifaximin
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
WO2009108730A2
(en)
|
2008-02-25 |
2009-09-03 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
EP3563850A1
(en)
|
2008-02-26 |
2019-11-06 |
Salix Pharmaceuticals, Ltd. |
Methods for treating bowel diseases
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
DK2294012T3
(da)
|
2008-05-07 |
2014-10-06 |
Salix Pharmaceuticals Ltd |
Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom
|
|
WO2010019511A2
(en)
|
2008-08-13 |
2010-02-18 |
Targanta Therapeutics Corp. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
DK2327407T3
(da)
|
2008-09-26 |
2014-08-25 |
Aska Pharm Co Ltd |
Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
US20100204173A1
(en)
|
2008-10-02 |
2010-08-12 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
JP5756020B2
(ja)
|
2008-12-10 |
2015-07-29 |
シプラ・リミテッド |
リファキシミン複合体
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
RU2540513C2
(ru)
|
2009-06-02 |
2015-02-10 |
Саликс Фармасьютикалз, Лтд. |
Способы лечения печеночной энцефалопатии
|
|
JP2013504597A
(ja)
|
2009-09-13 |
2013-02-07 |
サリックス ファーマスーティカルズ，リミテッド |
過敏性腸症候群（ｉｂｓ）の治療方法
|
|
JP6211768B2
(ja)
|
2009-10-27 |
2017-10-11 |
ルピン・リミテッド |
リファキシミンの固溶体
|
|
MX2012005883A
(es)
|
2009-11-23 |
2012-10-09 |
Cipla Ltd |
Composicion topica en espuma.
|
|
US8952159B2
(en)
|
2009-12-28 |
2015-02-10 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
EP2536282A4
(en)
|
2010-02-18 |
2013-07-03 |
Salix Pharmaceuticals Ltd |
METHOD FOR THE TREATMENT OF INFECTIONS
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
EP2544660B1
(en)
|
2010-03-10 |
2018-06-13 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
SG10201505484RA
(en)
|
2010-07-12 |
2015-09-29 |
Salix Pharmaceuticals Ltd |
Formulations of rifaximin and uses thereof
|
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
|
CA2825964A1
(en)
|
2011-02-11 |
2012-08-16 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
|
CA2834829A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
*
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
WO2013067394A1
(en)
|
2011-11-02 |
2013-05-10 |
Salix Pharmaceuticals, Ltd |
Methods for treating irritable bowel syndrome (ibs) and infections
|
|
JP2015509105A
(ja)
|
2012-01-25 |
2015-03-26 |
サリックス ファーマスーティカルズ，リミテッド |
リファキシミン誘導体及びその使用
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
|
JP2016510809A
(ja)
|
2013-03-15 |
2016-04-11 |
アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． |
膣感染症の治療に使用するためのリファキシミン
|
|
WO2014140995A2
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
|
AU2014252219B2
(en)
|
2013-04-12 |
2018-11-22 |
Alfasigma S.P.A. |
NSAID administration and related compositions, methods and systems.
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
US9765088B2
(en)
*
|
2014-04-19 |
2017-09-19 |
Granules India Limited |
Process for the preparation of rifamycin derivatives
|
|
CN106795192B
(zh)
|
2014-05-04 |
2020-06-16 |
萨利克斯药品公司 |
Ibs微生物群及其用途
|
|
KR102362719B1
(ko)
|
2014-05-12 |
2022-02-14 |
알파시그마 에스.피.에이. |
리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
EP3518924B1
(en)
|
2016-09-30 |
2022-08-10 |
Salix Pharmaceuticals, Inc. |
Solid dispersion forms of rifaximin
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
|
RU2020102511A
(ru)
|
2017-06-26 |
2021-07-27 |
Биофер С.П.А. |
Соединения пиридо-имидазо рифамицина в качестве антибактериального средства
|